Skip to content

Drug interactions

Avapritinib + Nilotinib

Severity: Major

Avapritinib and Nilotinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nilotinib may raise avapritinib exposure through CYP3A4 inhibition. Avapritinib is associated with intracranial hemorrhage, cognitive effects and QT concerns, so higher exposure is undesirable, and nilotinib itself prolongs QT.

What this interaction means in plain words

Avapritinib and Nilotinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Avapritinib belongs to Oncology; Nilotinib belongs to Oncology.

Evidence level: Low

Why it happens

CYP3A4 inhibition by nilotinib increases avapritinib levels, with possible additive QT effects.

What to do

Avoid the combination if possible. If it is necessary, follow avapritinib labeling for dose reduction with CYP3A4 inhibitors and monitor ECG and neurological status.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Avapritinib and Nilotinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Avapritinib with Nilotinib?

MediHelp rates the interaction as major. Avapritinib and Nilotinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Nilotinib may raise avapritinib exposure through CYP3A4 inhibition. Avapritinib is associated with intracranial hemorrhage, cognitive effects and QT concerns, so higher exposure is undesirable, and nilotinib itself prolongs QT.

How serious is the interaction between Avapritinib and Nilotinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible. If it is necessary, follow avapritinib labeling for dose reduction with CYP3A4 inhibitors and monitor ECG and neurological status.

What other medicines interact with Nilotinib?

MediHelp also lists interactions of Nilotinib with, for example, Amiodarone, Arsenic trioxide, Disopyramide. The full list is on the Nilotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in